Šio tyrimo tikslas palyginti diskų difuzijos ir automatizuotą metodus, nustatančius Enterobacteriaceae šeimos bakterijų plataus veikimo β-laktamazių (PVBLazių) fenotipą ir įvertinti PVBLazių paplitimą Vilniaus universiteto ligoninės Santariškių klinikose 2008-2010 metais. Tyrimų analizei buvo pasirinkta 58 Enterobacteriaceae šeimos bakterijos, išskirtos 2009-2011 metais ligoniams, besigydžiusiems Vilniaus Universiteto ligoninės Santariškių klinikose. Bakterijos ištirtos naudojant fenotipinius PVBL nustatymo metodus: automatizuotą Phoenix sistemą (Becton Dickenson, Sparks, MD, JAV), kombinuotą diskų difuzijos metodą ir dvigubos difuzijos metodą. Automatizuota Phoenix sistema tyrime laikyta kaip patvirtinantis metodas identifikuojant bakterijas ir nustatant PVBLazių gamybos fenotipą. Tiriamąją grupę sudarė šios bakterijų rūšys: K. pneumoniae, E.coli, Enterobacter spp., Proteus spp., Serratia spp., Morganella spp. ir Providencia spp.. Ištyrus 58 bakterijas patvirtinačiu metodu nustatyta, kad 31 iš jų gamina plataus veikimo beta-laktamazes. Atliktas palyginamasis diskų difuzijos metodų įvertinimas ir nustatytas jautrumas, specifiškumas, teigiama prognostinė vertė (PPV) ir neigiama prognostinė vertė (NPV). Įvertinus atliktų tyrimų duomenis nustatyta, kad kombinuoto diskų difuzijos metodo jautrumas - 100%, specifiškumas - 100%, PPV - 100%, NPV - 100%. Dvigubos difuzijos metodo jautrumas - 100%, specifiškumas – 88,9%, PPV – 91,2%, NPV - 100%. Gauti tyrimų rezultatai rodo, jog... [toliau žr. visą tekstą] / The aim of this study is to compare disk diffusion and automated methods for determining the Enterobacteriaceae extended spectrum-β-lactamases (ESBL) phenotype and to assess the prevalence of (ESBL) at University Hospital Clinics in 2008-2010. For the study were chosen 58 bacteria from the Enterobacteriaceae family that were isolated in 2009-2011 in patients that were treated at Vilnius University Hospital Clinic. The bacteria studied using phenotypic methods ESBL: Phoenix automated system (Becton Dickenson, Sparks, MD, USA) combined disc diffusion method and the double-diffusion method. Automated system of Phoenix for the study was considered as a method of confirming the identification of bacteria and determination of (ESBL) production phenotype. The studied group consisted of the following bacterial species: K. pneumoniae, E. coli, Enterobacter spp., Proteus spp., Serratia spp., Morganella spp. and Providencia spp . The examination with the validated method of 58 bacteria showed that 31 of them produce an extended spectrum beta lactamases. A performed comparative disc diffusion method was made and the evaluation of the sensitivity, specificity, positive prognostic value (PPV) and negative prognostic value (NPV) was identified. The evaluation of the data from studies showed that the combined disc diffusion method for sensitivity - 100% and specificity - 100%, PPV - 100%, NPV - 100%. Double-diffusion method for sensitivity - 100% and specificity - 88.9%, PPV - 91.2%... [to full text]

The objectives of this research were to evaluate the antibacterial activity and to determine the chemical composition of a list of medicinal plants used by Native Americans in California. Artemisia californica, Mimulus aurantiacus, Equisetum telmateia, Equisetum hyemale, and Marah fabacea were selected from a list of plants reported as having been used for ailments related to infections by tribes located in California. The extracts obtained through steam distillation from E. telmateia, E. hyemale and M. fabacea were assayed for in vitro antibacterial activity against 16 Gram-negative and 6 Gram-positive bacteria using disk diffusion assays and measuring the diameters of inhibition zones. E. telmateia showed the most promising antibacterial activity. The extracts from A. californica, M. aurantiacus and E. telmateia were analyzed for chemical composition, finding eucalyptol, thujone, eugenol, caryophyllene, germacrene D, and propanal as some of the secondary metabolites identified using GC-MS. Our results suggest that E. telmateia can be a potential source for novel antimicrobials against pathogenic bacteria.

Microbiological Project Using the Disc Diffusion Method for Lower Secondary School ABSTRACT This thesis deals with project-based education and his involvement in the functional structure of the czech educational theory and practice. It refers to the project as an innovative teaching process, which is qualitatively able to shield asked RVP requirements and the implementation of which contributes to the development of educational goals and core competencies. This thesis contains both theoretical aspects are developed through the study of literature and other sources in order to summarize the current state of knowledge of the subject, so practical. Theoretical bases emphasize not only on the characteristics of project-based education as such, but also on the appropriate application of educational strategies in the learning process. Specifically mentioned are possibilities of project-based teaching in the teaching of natural history, biology and ecology. The theoretical background followed by the practical part, which shifts the theory of project learning into practice. There is particular designed a project called "Strength of antibiotics", which is then implemented and reflected. Is described in detail during the planning, implementation and evaluation of the project. KEYWORDS: project-based education, school...

>Magister Scientiae - MSc / Different chlorhexidine (CHX) preparations and formulations are available in local markets. Some preparations contain anti-discoloration systems (ADS), additional antimicrobials like cetylpyridinium chloride (CPC), or alcohol. The aim of this study was to compare the antimicrobial efficacies of 3 different CHX preparations (Corsodyl®, Curasept® and GUM® Paroex®)

Bacterial bloodstream infections represent a severe and potentially life-threatening condition. Diagnostic tools, providing rapid species identification and antimicrobial susceptibility testing have a great impact on disease progression and treatment optimization. Typically, antimicrobial susceptibility testing involves a time-consuming process, and faster methods are likely to contribute in clinical settings. This study aimed to assess the reliability of the European Committee on Antimicrobial Susceptibility Testing (EUCAST) rapid antimicrobial susceptibility testing (RAST) with a 16-20-hour incubation period for implementation in a clinical microbiology laboratory. This method was conducted alongside the standardized disk diffusion method from EUCAST, encompassing all bacterial species compatible with 16-20-hour RAST. The method was executed 80 times, and over 450 readings were performed. It confirms EUCAST's method validation, affirming 16-20-hour RAST as a swift and precise method for blood bacterial resistance determination. All inhibition zones were readable, with 89% of antibiotics tested falling within 1 mm of the set target value. Notable deficiencies were observed in antibiotic-species combinations, such as trimethoprim/sulfamethoxazole and gentamicin against E. coli, and erythromycin against S. pneumoniae. Accurate interpretation of inhibition zones demands precise reading practices as some zones were ambiguous. The study also underscores the importance of overnight cultures in antimicrobial susceptibility testing via standardized disk diffusion, accentuating 16-20-hour RAST's pivotal role in potentially accelerating resistance determination by up to a day. Given its commendable performance, 16-20-hour RAST is ready to be incorporated into the standard procedures at clinical microbiology laboratories, as demonstrated by its successful adoption at Unilabs, Skövde.

Actinomycosis is an infrequent bacterial infection involving Actinomyces spp and related organisms which may occur at many body sites. It can also be found in the microbiota. Actinomyces spp are described as gram-positive bacilli whereas some species grow strictly anaerobically and some facultative. Culturing is a standardized method when suspecting actinomycosis and can be a diagnostic challenge because of inhibition of microbiota and slow growth. Enriched agar plates are used when culturing fastidious bacteria and may be more selective when including antibiotics. The aim of this project was to evaluate if using antibiotic disc facilitates identification of Actinomyces spp when mixed with microbiota. A mix of microbiota was made by pooling together several species. The susceptibility of different isolates and microbiota was analysed using antibiotic discs to determine which disc to use in a trial. A trial was done by inoculating the isolates with the microbiota on agar plates, dispensing ciprofloxacin, and trimethoprim discs. A control group without antibiotic discs were also tested. Results showed variance for most isolates susceptibility. No disc performed superior in the trial, but ciprofloxacin on FAA plates incubated anaerobically gave slightly higher recovery. Both discs facilitated identification of some isolates by supressing much microbiota. Considering that the isolates had varying susceptibility it may be problematic to find one common disc. This study has given new insights on what may facilitate identification. Further studies are needed to determine if antibiotic discs could facilitate identification of Actinomyces and needs testing on clinical samples using larger sample size.

A administração indiscriminada de antimicrobianos sistêmicos tem como principais efeitos indesejáveis a seleção antimicrobiana, hipersensibilidade, comprometimento gastrointestinal e toxicidade. A busca por uma alternativa à terapêutica antimicrobiana sistêmica em Odontologia através do uso de um material biodegradável de aplicação local pode apresentar inúmeras vantagens. As características estruturais, de citocompatibilidade e facilidade de fabricação do polímero sintético ácido poli-L-lactídeo (PLLA) permitem que este seja um carreador de fármacos como amoxicilina (AM), azitromicina (AZ), clindamicina (CL) ou metronidazol (ME) mantendo concentrações inibitórias constantes e por tempo prolongado, sendo capazes de prevenir a colonização dos principais patógenos orais. Objetivo: Avaliar e comparar o comportamento de filmes ou malhas de PLLA associados aos quatro antimicrobianos mais utilizados em Odontologia como uma alternativa local. Metodologia: 180 (N) discos poliméricos com 15 ou 6 mm de diâmetro foram preparados em associação a 20% do antimicrobiano amoxicilina, azitromicina, clindamicina ou metronidazol sendo classificados como grupo F (filme) e M (malha). Foram confeccionados segundo os métodos de deposição e eletrofiação (fibras) respectivamente. Todos os discos foram armazenados em solução tampão (pH 5 ou 7.4) e alíquotas foram coletadas e analisadas por cromatografia líquida de alta performace (HPLC) em 8, 24, 48, 72, 96, 120, 144 e 168 horas. As espécimes foram pesadas após 3 e 6 meses de armazenamento nas soluções tampões para análise de degradação. Para a análise de citotoxicidade, os materiais foram cultivados com fibroblastos humanos por 24h, 48h e 72h e analisados por ensaio de MTT. A capacidade antimicrobiana dos discos foi determinada em cultura de P.gingivalis e S.pyogenes. Para o controle estrutural foram realizadas fotografias digitais e MEV dos espécimes controle, das interfaces (criofratura) e das espécimes degradadas. Resultados: A liberação farmacológica para os antimicrobianos na ordem pH levemente básico (7.4) e ácido (5.0) foi respectivamente: ME 70.03% (F) e 100% (M); 88,01% (F) e 19,4% (M). Para AM 38,73% (F) e 18,63% (M); 61,44% (F) e 47,93% (M). Para AZ 32,53% (F) e 82,85% (M); 46,78% (F) e 73,15% (M). Para CL 68,42% (F) e 81,10% (M); 76,47% (F) e 72,76% (M). A análise antimicrobiana demonstrou capacidade inibitória para S.pyogenes e P.gingivalis para todos os materiais testados, não havendo diferença significativa entre filme e malha dentro de cada grupo (p>0.05). A reação de citotoxicidade por MTT comprovou que os biomateriais testados são compatíveis com fibroblastos humanos e mais citocompatíveis que o controle PLLA, controle de vida e morte (p<0.05). As malhas demonstraram favorecimento do crescimento celular principalmente em 24 e 48 horas. A MEV demonstra um filme com superfície rugosa e malha com fibras e poros mimetizando a matriz extracelular. Após criofratura a MEV da interface comprovou incorporação do fármaco ao filme e malha, exceto para o ME, com cristais externos ao polímero. Após a degradação, os filmes de amoxicilina apresentaram maior degradação que PLLA no pH 5.0 (p=0.007) e pH 7.4 (p=0.046). Já para as malhas a azitromicina apresentou maior degradação que PLLA no pH 7.4 (p=0.031). Conclusão: O PLLA é um polímero cuja associação aos antimicrobianos utilizados mostrou-se segura, citocompatível e promissora na liberação de doses inibitórias contra os microrganismos P.gingivalis e S. pyogenes. A liberação farmacológica foi influenciada pela característica química do fármaco, apresentação do polímero (filme e malha) e pH da solução de armazenamento. Este estudo comprovou ser possível através de uma terapêutica medicamentosa local controlar ou prevenir infecções localizadas, sem que seja necessário o fármaco sistêmico. / Indiscriminate administration of systemic antimicrobial has undesirable effects such as antimicrobial selection, hypersensitivity, gastrointestinal commitment and toxicity. For an alternative to systemic antimicrobial therapy in Dentistry, use a biodegradable material of local application can present numerous advantages. The structural characteristics, cytocompatibility and ease of fabrication of the synthetic polymer poly-L- lactide acid (PLLA) enable this to be a carrier biomaterial. When associated with antimicrobials as amoxicillin (AM), azithromycin (AZ), clindamycin (CL) or metronidazole (ME) it can maintain constant the inhibitory concentrations for a long time, being able to prevent colonization of the main oral pathogens. Objective: To evaluate and compare the behavior of PLLA associated with the most useful antimicrobials in Dentistry as an alternative for prevention and treatment of infections. Methodology: 180 (N) polymer discs with 15 or 6 mm diameter were prepared in association with the antimicrobial concentration of 20% amoxicillin, metronidazole, clindamycin or azithromycin being classified as Group F (film) and M (mesh). They were made using the methods of deposition and electrospinning (nanofibers) respectively. All discs were stored in buffer solutions (pH 5 or 7.4) and aliquots were collected and analyzed by high performance chromatography (HPLC) on 8, 24, 48, 72, 96, 120 , 144 and 168 hours. Cytotoxicity of human fibroblasts was tested after 24h, 48h and 72h by the MTT reaction. The antimicrobial capacity of the disks was determined against P. gingivalis and S. pyogenes cultures. The specimens were weighed after 3 and 6 months of storage for degradation analysis. Specimens were also carried out by digital photos for structural control. SEM was used to control interfaces (freeze-fracture) and degradation description. Results: The drug release for antimicrobials in order slightly basic pH (7.4) and acid ( 5.0 ) was respectively : ME 70.03 % (F ) and 100% (M ) ; 88.01 % (F) and 19.4 % ( F ) . For AM 38.73 % (F) and 18.63% ( F ) ; 61.44 % (F) and 47.93 % ( F ) . To AZ 32.53 % (F) and 82.85 % (F ) ; 46.78 % (F) and 73.15% ( F ) . Cl 68.42 % (F) and 81.10 % ( F ) ; 76.47 % (F) and 72.76 % ( F ) . Antimicrobial analysis showed inhibitory capacity against S. pyogenes and P. gingivalis for all tested polymers. ANOVA showed no difference between film and mesh within each group (p> 0.05). The MTT reaction demonstrated that the biomaterials tested are compatible with human fibroblasts (p < 0.05). The meshes have shown a tendency to cell growth especially in 24 to 48 hours. The SEM images showed a film with a rough surface and mesh of nanofibers and pores mimicking the extracellular matrix and also proved incorporation of the drug to the film and mesh after the freeze-fracture interface, except for ME that was external to the polymer crystals. Degradation showed differences among Amoxicillin-film and PLLA pH 5.0 (p = 0.007) and pH 7.4 (p = 0.046). As for the meshes differences occurred only between azithromycin and the PLLA pH 7.4 (p = 0.031). Conclusion: The PLLA is a polymer biomaterial whose association to antimicrobial is safe, biocompatible and promising. It can inhibit P. gingivalis and S. pyogenes microorganisms. The drug release was influenced by the chemical characteristics of the drug, polymer performance (mesh and film) and the pH of the storage solution. This study proved a local drug system therapy to control or prevent localized infections without systemic doses.

Malassezia pachydermatis is an opportunistic fungus associated to dermatomycoses and otopathies in domestic and wild animals. The aim of this study was to compare the susceptibility profile of clinical isolates of M. pachydermatis against topic and systemic antifungals, through two standardized CLSI techniques: broth microdilution (M27-A3, 2008) and disk diffusion (M44-A, 2004). A standard Candida albicans strain (ATCC 28367) was used as quality control. M. pachydermatis isolates assayed through the broth microdilution method showed susceptibility to anfotericina-B (100%), fluconazole (97,83%), ketoconazole (95.66%), itraconazole (93,48%), followed by clotrimazole and miconazole (86.96%). The disk diffusion method showed susceptibility of 97,83% to nystatin, 95,66% to itraconazole and to amphotericin B, 91,32% to ketoconazole, 89,14% to fluconazole and of 86.96% to miconazole and clotrimazole. Through the in vitro induction of resistance to fluconazole (100%), cross-resistance was observed through the broth microdilution method among the 30 M. pachydermatis isolates against the azoles itraconazole (93%), ketoconazole (97%) and voriconazole (100%). The study of the activities of the essential oils obtained through the broth microdilution, based on geometric means of the minimum fungicidal concentration, showed that concentrations above 195.42 μg/mL, 332.49 μg/mL and 448.8 μg/mL of oregano, Mexican oregano and cinnamon essential oils, respectively, have fungicidal action against M. pachydermatis, independently of the sensitivity or resistance to fluconazole. The fungicidal activity of the essential oils against fluconazole-resistant M. pachydermatis strains is important for further therapeutic studies of this mycosis. Despite the susceptibility observed among sensitive M. pachydermatis strains suggesting fluconazole as a safe drug for the treatment of most cases of superficial and invasive malasseziosis, it is essential continuous surveillance studies to detect changes in the microbiological profile due to therapeutic practices. / Malassezia pachydermatis é um fungo oportunista, associado à dermatomicoses e otopatias em animais domésticos e selvagens. O objetivo deste estudo foi comparar o perfil de susceptibilidade de isolados clínicos de M. pachydermatis frente antifúngicos tópicos e sistêmicos, através de duas técnicas padronizadas pelo CLSI: microdiluição em caldo (M27- A3, 2008) e disco-difusão (M44-A, 2004). Para todos os testes foi utilizada uma cepa padrão de Candida albicans (ATCC 28367) como controle de qualidade. Isolados de M. pachydermatis testados através do método de microdiluição em caldo apresentaram em ordem decrescente de susceptibilidade: anfotericina-B (100%), fluconazol (97,83%), cetoconazol (95,66%), itraconazol (93.48%), seguido de clotrimazol e miconazol (86,96%). Pelo método de disco-difusão 97,83% dos isolados foram suscetíveis a nistatina, 95,66% ao itraconazol e a anfotericina-B; 91,32% ao cetoconazol, 89,14% ao fluconazol; e 86,96% ao miconazol e clotrimazol. Através da indução de resistência in vitro, de 30 isolados de M. pachydermatis, ao fluconazol (100%) foi possível evidenciar resistência cruzada pelo método de microdiluição em caldo frente aos antifúngicos azólicos, itraconazol (93%), cetoconazol (97%) e voriconazol (100%). O estudo da atividade de óleos essenciais gerados pelo método de microdiluição em caldo, baseado nas médias geométricas das CFMs, evidenciou-se que concentrações acima de 195.42 μg/mL de óleo essencial de orégano, 332.49 μg/mL de óleo essencial de orégano mexicano e 448.8 μg/mL de óleo essencial de canela, possuem ação fungicida in vitro sobre M. pachydermatis, independente da sensibilidade ou resistência ao fluconazol. A atividade de óleos essenciais frente M. pachydermatis fluconazol resistente, é um achado que consolida a importância destes para estudos futuros voltados a terapêutica desta micose. Apesar dos dados de susceptibilidade apresentados pelas cepas sensíveis de M. pachydermatis sugerirem que o fluconazol ainda é uma droga segura para terapêutica da maioria dos casos de malasseziose superficial ou invasiva, é fundamental que estudos de vigilância epidemiológica sejam realizados continuamente para evidenciar mudanças no perfil microbiológico em função de práticas terapêuticas.

A administração indiscriminada de antimicrobianos sistêmicos tem como principais efeitos indesejáveis a seleção antimicrobiana, hipersensibilidade, comprometimento gastrointestinal e toxicidade. A busca por uma alternativa à terapêutica antimicrobiana sistêmica em Odontologia através do uso de um material biodegradável de aplicação local pode apresentar inúmeras vantagens. As características estruturais, de citocompatibilidade e facilidade de fabricação do polímero sintético ácido poli-L-lactídeo (PLLA) permitem que este seja um carreador de fármacos como amoxicilina (AM), azitromicina (AZ), clindamicina (CL) ou metronidazol (ME) mantendo concentrações inibitórias constantes e por tempo prolongado, sendo capazes de prevenir a colonização dos principais patógenos orais. Objetivo: Avaliar e comparar o comportamento de filmes ou malhas de PLLA associados aos quatro antimicrobianos mais utilizados em Odontologia como uma alternativa local. Metodologia: 180 (N) discos poliméricos com 15 ou 6 mm de diâmetro foram preparados em associação a 20% do antimicrobiano amoxicilina, azitromicina, clindamicina ou metronidazol sendo classificados como grupo F (filme) e M (malha). Foram confeccionados segundo os métodos de deposição e eletrofiação (fibras) respectivamente. Todos os discos foram armazenados em solução tampão (pH 5 ou 7.4) e alíquotas foram coletadas e analisadas por cromatografia líquida de alta performace (HPLC) em 8, 24, 48, 72, 96, 120, 144 e 168 horas. As espécimes foram pesadas após 3 e 6 meses de armazenamento nas soluções tampões para análise de degradação. Para a análise de citotoxicidade, os materiais foram cultivados com fibroblastos humanos por 24h, 48h e 72h e analisados por ensaio de MTT. A capacidade antimicrobiana dos discos foi determinada em cultura de P.gingivalis e S.pyogenes. Para o controle estrutural foram realizadas fotografias digitais e MEV dos espécimes controle, das interfaces (criofratura) e das espécimes degradadas. Resultados: A liberação farmacológica para os antimicrobianos na ordem pH levemente básico (7.4) e ácido (5.0) foi respectivamente: ME 70.03% (F) e 100% (M); 88,01% (F) e 19,4% (M). Para AM 38,73% (F) e 18,63% (M); 61,44% (F) e 47,93% (M). Para AZ 32,53% (F) e 82,85% (M); 46,78% (F) e 73,15% (M). Para CL 68,42% (F) e 81,10% (M); 76,47% (F) e 72,76% (M). A análise antimicrobiana demonstrou capacidade inibitória para S.pyogenes e P.gingivalis para todos os materiais testados, não havendo diferença significativa entre filme e malha dentro de cada grupo (p>0.05). A reação de citotoxicidade por MTT comprovou que os biomateriais testados são compatíveis com fibroblastos humanos e mais citocompatíveis que o controle PLLA, controle de vida e morte (p<0.05). As malhas demonstraram favorecimento do crescimento celular principalmente em 24 e 48 horas. A MEV demonstra um filme com superfície rugosa e malha com fibras e poros mimetizando a matriz extracelular. Após criofratura a MEV da interface comprovou incorporação do fármaco ao filme e malha, exceto para o ME, com cristais externos ao polímero. Após a degradação, os filmes de amoxicilina apresentaram maior degradação que PLLA no pH 5.0 (p=0.007) e pH 7.4 (p=0.046). Já para as malhas a azitromicina apresentou maior degradação que PLLA no pH 7.4 (p=0.031). Conclusão: O PLLA é um polímero cuja associação aos antimicrobianos utilizados mostrou-se segura, citocompatível e promissora na liberação de doses inibitórias contra os microrganismos P.gingivalis e S. pyogenes. A liberação farmacológica foi influenciada pela característica química do fármaco, apresentação do polímero (filme e malha) e pH da solução de armazenamento. Este estudo comprovou ser possível através de uma terapêutica medicamentosa local controlar ou prevenir infecções localizadas, sem que seja necessário o fármaco sistêmico. / Indiscriminate administration of systemic antimicrobial has undesirable effects such as antimicrobial selection, hypersensitivity, gastrointestinal commitment and toxicity. For an alternative to systemic antimicrobial therapy in Dentistry, use a biodegradable material of local application can present numerous advantages. The structural characteristics, cytocompatibility and ease of fabrication of the synthetic polymer poly-L- lactide acid (PLLA) enable this to be a carrier biomaterial. When associated with antimicrobials as amoxicillin (AM), azithromycin (AZ), clindamycin (CL) or metronidazole (ME) it can maintain constant the inhibitory concentrations for a long time, being able to prevent colonization of the main oral pathogens. Objective: To evaluate and compare the behavior of PLLA associated with the most useful antimicrobials in Dentistry as an alternative for prevention and treatment of infections. Methodology: 180 (N) polymer discs with 15 or 6 mm diameter were prepared in association with the antimicrobial concentration of 20% amoxicillin, metronidazole, clindamycin or azithromycin being classified as Group F (film) and M (mesh). They were made using the methods of deposition and electrospinning (nanofibers) respectively. All discs were stored in buffer solutions (pH 5 or 7.4) and aliquots were collected and analyzed by high performance chromatography (HPLC) on 8, 24, 48, 72, 96, 120 , 144 and 168 hours. Cytotoxicity of human fibroblasts was tested after 24h, 48h and 72h by the MTT reaction. The antimicrobial capacity of the disks was determined against P. gingivalis and S. pyogenes cultures. The specimens were weighed after 3 and 6 months of storage for degradation analysis. Specimens were also carried out by digital photos for structural control. SEM was used to control interfaces (freeze-fracture) and degradation description. Results: The drug release for antimicrobials in order slightly basic pH (7.4) and acid ( 5.0 ) was respectively : ME 70.03 % (F ) and 100% (M ) ; 88.01 % (F) and 19.4 % ( F ) . For AM 38.73 % (F) and 18.63% ( F ) ; 61.44 % (F) and 47.93 % ( F ) . To AZ 32.53 % (F) and 82.85 % (F ) ; 46.78 % (F) and 73.15% ( F ) . Cl 68.42 % (F) and 81.10 % ( F ) ; 76.47 % (F) and 72.76 % ( F ) . Antimicrobial analysis showed inhibitory capacity against S. pyogenes and P. gingivalis for all tested polymers. ANOVA showed no difference between film and mesh within each group (p> 0.05). The MTT reaction demonstrated that the biomaterials tested are compatible with human fibroblasts (p < 0.05). The meshes have shown a tendency to cell growth especially in 24 to 48 hours. The SEM images showed a film with a rough surface and mesh of nanofibers and pores mimicking the extracellular matrix and also proved incorporation of the drug to the film and mesh after the freeze-fracture interface, except for ME that was external to the polymer crystals. Degradation showed differences among Amoxicillin-film and PLLA pH 5.0 (p = 0.007) and pH 7.4 (p = 0.046). As for the meshes differences occurred only between azithromycin and the PLLA pH 7.4 (p = 0.031). Conclusion: The PLLA is a polymer biomaterial whose association to antimicrobial is safe, biocompatible and promising. It can inhibit P. gingivalis and S. pyogenes microorganisms. The drug release was influenced by the chemical characteristics of the drug, polymer performance (mesh and film) and the pH of the storage solution. This study proved a local drug system therapy to control or prevent localized infections without systemic doses.

Made available in DSpace on 2016-07-18T17:53:17Z (GMT). No. of bitstreams: 1 Carolina Silva Guimaraes Pereira.pdf: 713350 bytes, checksum: d2adc7dea782d58a041a7b1b5991ba9c (MD5) Previous issue date: 2016-05-06 / This study aims to evaluate the microbial sensitivity profile of bacteria isolated from the eyes of dogs with keratoconjunctivitis sicca (KCS). We evaluated 65 dogs (n=65) diagnosed with KCS and 30 healthy dogs (c=30) (control group). After diagnosis of KCS, conjunctival swabs were collected and the microbiological examinations performed under aerobic culture, antibiogram and minimum inhibitory concentration (MIC) for the antibiotics chloramphenicol, tobramycin, ofloxacin and moxifloxacin. With respect to the sensitivity to the tested antibiotics, polymyxin B, tobramycin and chloramphenicol obtained that highest percentages and tetracycline the lowest percentage. Regarding the results of the MIC, the fifteen most resistant strains of Staphylococcus pseudintermedius and the fifteen most resistant strains of Gram-negative were selected. For S. pseudintermedius, tobramycin demonstrated the highest percentage of sensitivity and ofloxacin and moxifloxacin the lowest. For Gram-negative, ofloxacina and moxifloxacina demonstrated (100%) of sensitivity, tobramycin (93,3%) and chloramphenicol (80%). Three multi-resistant strains of S. pseudintermedius were detected, one with isolated sensitivity to cefazolin, another to vancomycin and another to polymyxin B and amikacin. Remission from bacterial infection was achieved after 15 days in 100% of the animals topically treated with antibiotics selected according to the sensitivity. The bacteria isolated from the eyes of dogs with KCS presented variable sensitivity to the tested antibiotics, according to the species considered. The emergence of quinolone-resistant strains of S. pseudintermedius, with higher prevalence detected in the eyes, reinforces the need to identify the bacteria involved and antimicrobial susceptibility profile, as secondary infections, can be an aggravating and perpetuating factor of KCS. / Objetivou-se avaliar o perfil de sensibilidade microbiana de bactérias isoladas dos olhos de cães com ceratoconjuntivite seca (CCS). Foram avaliados 65 cães (n=65) diagnosticados com CCS e 30 cães (c=30) hígidos para o grupo controle. Foram coletados swabs conjuntivais e realizados os exames microbiológicos cultura em aerobiose, antibiograma e concentração inibitória mínima (CIM) para os antibióticos cloranfenicol, tobramicina, ofloxacina e moxifloxacina. Com relação à sensibilidade dos antibióticos testados, a polimixina B, a tobramicina e o cloranfenicol obtiveram maior percentual, enquanto que a tetraciclina o menor percentual. Com relação aos resultados da CIM, foram selecionadas as quinze cepas mais resistentes dos Staphylococcus pseudintermedius e as quinze cepas mais resistentes dos Gram-negativos. Para S. pseudintermedius a tobramicina expressou maior percentual de sensibilidade e a ofloxacina e moxifloxacina menor. Para Gram-negativos, ofloxacina e moxifloxacina apresentaram (100%) de sensibilidade, tobramicina (93,3%) e cloranfenicol (80%). Foram detectadas 3 linhagens de S. pseudintermedius multirresistentes, sendo um isolado sensível à cefazolina, outro a vancomicina e outro a polimixina B e amicacina. Em 100% dos animais tratados topicamente com os antibióticos selecionados pela sensibilidade, obteve-se a remissão da infecção bacteriana após 15 dias. As bactérias isoladas de olhos de cães com CCS possuem sensibilidade variável frente aos antibióticos testados, de acordo com a espécie considerada. A emergência de linhagens quinolona-resistentes de S. pseudintermedius, agente de prevalência mais alta detectada nesses olhos, reforça a necessidade de identificação da bactéria envolvida e perfil de sensibilidade microbiana, visto que a infecção secundária, pode ser um fator agravante e perpetuante da CCS.